Sign In
Buy STAA
$28.26
-0.230 (-0.81%)
At Close: Jun 03, 2026
Staar Surgical (STAA) Q1 Earnings and Revenues Beat Estimates
07:34pm, Wednesday, 04'th May 2022
Staar Surgical (STAA) delivered earnings and revenue surprises of 81.25% and 5.66%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
STAAR Surgical Company's (STAA) CEO Caren Mason on Q1 2022 Results - Earnings Call Transcript
07:17pm, Wednesday, 04'th May 2022
STAAR Surgical Company (NASDAQ:STAA ) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Brian Moore - Vice President, Investor, Media Relations and Corporate Development Car
After Falling More Than 56% in a Year, Is STAAR Surgical Doomed?
02:45pm, Wednesday, 04'th May 2022 The Motley Fool
The stock price isn't tightly connected to its fundamentals.
After Falling More Than 56% in a Year, Is STAAR Surgical Doomed?
10:45am, Wednesday, 04'th May 2022
The stock price isn't tightly connected to its fundamentals.
Why STAAR Surgical Stock Dropped 12% This Week
09:02pm, Thursday, 28'th Apr 2022 The Motley Fool
Concerns about a potential drop in consumer spending may have hurt the stock.
Why STAAR Surgical Stock Dropped 12% This Week
05:02pm, Thursday, 28'th Apr 2022
Concerns about a potential drop in consumer spending may have hurt the stock.
West Pharmaceutical Services (WST) Q1 Earnings Top Estimates
11:25am, Thursday, 28'th Apr 2022 Zacks Investment Research
West Pharmaceutical (WST) delivered earnings and revenue surprises of 5.50% and 0.63%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Clearbridge Small Cap Growth Strategy Portfolio Manager Commentary Q1 2022
04:23am, Friday, 15'th Apr 2022 Seeking Alpha
ClearBridge Small Cap Growth Strategy underperformed its index benchmark during Q1. Who were the leading detractors and contributors? Click here to find out.
Is STAAR Surgical A Watchlist Contender?
01:22am, Sunday, 10'th Apr 2022
STAAR has a 20% 5-year average of year over year revenue growth and high gross margins of 77.5% for 2021 and 72.4% for 2020.
Needham Sees Clear View Into STAAR Surgical's Durable Double-Digit Revenue Expansion
06:59pm, Friday, 08'th Apr 2022 Benzinga
Needham is initiating coverage on STAAR Surgical Company (NASDAQ: STAA) with a Buy rating and an $87 price target.
The analysts note that FDA approval of STAA's EVO Implantable Collamer Lens (ICL
Benzinga's Top Ratings Upgrades, Downgrades For April 8, 2022
02:03pm, Friday, 08'th Apr 2022 Benzinga
Upgrades
UBS upgraded the previous rating for First Republic Bank (NYSE:FRC) from Neutral to Buy. For the fourth quarter, First Republic Bank had an EPS of $2.02, compared to year-ago quarter EPS of $
STAAR Surgical Surged Today: Is the Stock a Buy Now?
08:16pm, Monday, 28'th Mar 2022 The Motley Fool
The company should have brighter days ahead with the FDA approval of the EVO implantable lens.
STAAR Surgical Surged Today: Is the Stock a Buy Now?
04:16pm, Monday, 28'th Mar 2022
The company should have brighter days ahead with the FDA approval of the EVO implantable lens.
Why STAAR Surgical Stock Is Surging Today
03:56pm, Monday, 28'th Mar 2022 The Motley Fool
The FDA approved the company's EVO implantable lens for nearsightedness.
Tesla Plans Another Stock Split, but This Tiny Nasdaq Stock Jumped Even More
12:18pm, Monday, 28'th Mar 2022 The Motley Fool
Investors hope for another solid week for the Nasdaq Composite.
